The DOI matches its Crossref record; 397 of the 397 references it cites were found in a registry or an index.
Carbohydrate-based drugs launched during 2000−2021
Open accessAbstract
Carbohydrates are fundamental molecules involved in nearly all aspects of lives, such as being involved in formating the genetic and energy materials, supporting the structure of organisms, constituting invasion and host defense systems, and forming antibiotics secondary metabolites. The naturally occurring carbohydrates and their derivatives have been extensively studied as therapeutic agents for the treatment of various diseases. During 2000 to 2021, totally 54 carbohydrate-based drugs which contain carbohydrate moities as the major structural units have been approved as drugs or diagnostic agents. Here we provide a comprehensive review on the chemical structures, activities, and clinical trial results of these carbohydrate-based drugs, which are categorized by their indications into antiviral drugs, antibacterial/antiparasitic drugs, anticancer drugs, antidiabetics drugs, cardiovascular drugs, nervous system drugs, and other agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–397 of 397
Curing HIV: Seeking to Target and Clear Persistent Infection
Margolis, D. M., Archin, N. M., Cohen, M. S., Eron, J. J., Ferrari, G., Garcia, J. V., Gay, C. L., Goonetilleke, N., Joseph, S. B., Swanstrom, R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.005 · Cited by 178
Translation and Protein Synthesis: Macrolides
Katz, L., & Ashley, G. W. (2005) · Chemical Reviews · doi:10.1021/cr030107f · Cited by 177
Intratympanic gentamicin for Ménière's disease or syndrome
Pullens, B., & van Benthem, P. P. G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008234.pub2 · Cited by 175
Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic
Graham, B. S., & Sullivan, N. J. (2018) · Nature Immunology · doi:10.1038/s41590-017-0007-9 · Cited by 175
Ohtake, Y., Sato, T., Kobayashi, T., Nishimoto, M., Taka, N., Takano, K., Yamamoto, K., Ohmori, M., Yamaguchi, M., Takami, K., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300884k · Cited by 174
Schroit, A. J., & Fidler, I. J. (1982) · PubMed · Cited by 171
Ren, Z., Luo, H., Yu, Z., Song, J., Liang, L., Wang, L., Wang, H., Cui, G., Liu, Y., Wang, J., et al. (2020) · Advanced Science · doi:10.1002/advs.202001435 · Cited by 171
Self-citationLunde, C. S., Hartouni, S. R., Janc, J. W., Mammen, M., Humphrey, P. P., & Benton, B. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01710-08 · Cited by 170
Pratley, R. E., Eldor, R., Raji, A., Golm, G., Huyck, S. B., Qiu, Y., Sunga, S., Johnson, J., Terra, S. G., Mancuso, J. P., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13194 · Cited by 162
Carbohydrates: A Frontier in Medicinal Chemistry
Stallforth, P., Lepenies, B., Adibekian, A., & Seeberger, P. H. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900819p · Cited by 161
Total Syntheses of Vancomycin-Related Glycopeptide Antibiotics and Key Analogues
Okano, A., Isley, N. A., & Boger, D. L. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00820 · Cited by 161
Clay, K. D., Hanson, J. S., Pope, S. D., Rissmiller, R. W., Purdum, P. P., & Banks, P. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-6-200503210-00121 · Cited by 160
A 40-Year Journey in Search of Selective Antiviral Chemotherapy*
De Clercq, E. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100228 · Cited by 159
Kakinuma, H., Oi, T., Hashimoto-Tsuchiya, Y., Arai, M., Kawakita, Y., Fukasawa, Y., Iida, I., Hagima, N., Takeuchi, H., Chino, Y., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901893x · Cited by 159
Takamura, E., Tsubota, K., Watanabe, H., Ohashi, Y., & for The Diquafosol Ophthalmic Solution Phase 3 Study Group (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-301448 · Cited by 159
Ipragliflozin: First Global Approval
Poole, R. M., & Dungo, R. T. (2014) · Drugs · doi:10.1007/s40265-014-0204-x · Cited by 158
Li, Y., Kuang, K., Yerxa, B., Wen, Q., Rosskothen, H., & Fischbarg, J. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.2.c595 · Cited by 158
Protein-Carbohydrate Interactions Studied by NMR: From Molecular Recognition to Drug Design
Fernández-Alonso, M. D. C., Díaz, D., Berbis, M. A., Marcelo, F., Cañada, F. J., & Jiménez‐Barbero, J. (2012) · Current Protein and Peptide Science · doi:10.2174/138920312804871175 · Cited by 157
Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia
Lee, J. S., Giesler, D. L., Gellad, W. F., & Fine, M. J. (2016) · JAMA · doi:10.1001/jama.2016.0115 · Cited by 157
Dagogo-Jack, S. E., Liu, J., Eldor, R., Amorín, G. S., Johnson, J. R., Hille, D. A., Liao, Y., Huyck, S. B., Golm, G. T., Terra, S. G., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13116 · Cited by 157
Formation of Unusual Sugars: Mechanistic Studies and Biosynthetic Applications
He, X., & Liu, H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135339 · Cited by 156
Protein kinase inhibition of clinically important staurosporine analogues
Gani, O. A. B. S. M., & Engh, R. A. (2010) · Natural Product Reports · doi:10.1039/b923848b · Cited by 154
Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances
Kizek, R., Adam, V., Hraběta, J., Eckschlager, T., Smutný, S., Burda, J. V., Frei, E., & Stiborová, M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.07.006 · Cited by 151
Grunberger, G., Camp, S. J., Johnson, J. R., Huyck, S. B., Terra, S. G., Mancuso, J. P., Jiang, Z. W., Golm, G. T., Engel, S. S., & Lauring, B. P. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0337-5 · Cited by 151
Carbohydrate chemistry in drug discovery
Galán, M. C., Benito‐Alifonso, D., & Watt, G. M. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob01017k · Cited by 150
Khanna, R., Soska, R., Lun, Y., Feng, J., Frascella, M., Young, B. L., Brignol, N., Pellegrino, L. J., Sitaraman, S., Desnick, R. J., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.220 · Cited by 149
Garza‐Ramos, G., Xiong, L., Zhong, P., & Mankin, A. S. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6898-6907.2001 · Cited by 149
Terra, S. G., Focht, K., Davies, M. J., Frías, J. P., Derosa, G., Darekar, A., Golm, G. T., Johnson, J. R., Saur, D., Lauring, B. P., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12888 · Cited by 148
Sondak, V. K., King, D. W., Zager, J. S., Schneebaum, S., Kim, J. S., Leong, S. P. L., Faries, M. B., Averbook, B. J., Martinez, S. R., Puleo, C. A., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2612-z · Cited by 147
New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis
Reiter, A., George, T. I., & Gotlib, J. R. (2020) · Blood · doi:10.1182/blood.2019000932 · Cited by 147
Seino, Y., Sasaki, T., Fukatsu, A., Ubukata, M., Sakai, S., & Samukawa, Y. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.912983 · Cited by 146
Fabbro, D., Buchdunger, E., Wood, J., Mestan, J., Hofmann, F., Ferrari, S. M., Mett, H., O’Reilly, T., & Meyer, T. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00005-4 · Cited by 145
Sentinel-Lymph-Node Biopsy for Cutaneous Melanoma
Gershenwald, J. E., & Ross, M. I. (2011) · New England Journal of Medicine · doi:10.1056/nejmct1002967 · Cited by 144
Crich, D. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c11106 · Cited by 144
Imamura, M., Nakanishi, K., Suzuki, T., Ikegai, K., Shiraki, R., Ogiyama, T., Murakami, T., Kurosaki, E., Noda, A., Kobayashi, Y., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.051 · Cited by 139
Mascitti, V., Maurer, T. S., Robinson, R. P., Bian, J., Boustany, C., Brandt, T. A., Collman, B. M., Kalgutkar, A. S. S., Klenotic, M. K., Leininger, M. T., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200049r · Cited by 138
Matsumoto, Y., Ohashi, Y., Watanabe, H., & Tsubota, K. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.04.010 · Cited by 137
Drug development for alzheimer’s disease: Microglia induced neuroinflammation as a target
Dong, Y., Li, X., Cheng, J., & Hou, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030558 · Cited by 136
Kurosaki, E., & Ogasawara, H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.003 · Cited by 136
Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation
Marton, A., Kaneko, T., Kovalik, J., Yasui, A., Nishiyama, A., Kitada, K., & Titze, J. M. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00350-x · Cited by 136
Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma
Meyers, P. A. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.69 · Cited by 134
Sugar-mimicking glycosidase inhibitors: bioactivity and application
Asano, N. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8522-3 · Cited by 134
Developments in Carbohydrate-Based Cancer Therapeutics
Hossain, F., & Andreana, P. R. (2019) · Pharmaceuticals · doi:10.3390/ph12020084 · Cited by 134
Xie, K. C., & Plunkett, W. K. (1996) · PubMed · Cited by 133
Kinase Inhibitors of Marine Origin
Bharate, S. B., Sawant, S. D., Singh, P. P., & Vishwakarma, R. A. (2013) · Chemical Reviews · doi:10.1021/cr300410v · Cited by 133
More than 80 clinical trials launch to test coronavirus treatments
Maxmen, A. (2020) · Nature · doi:10.1038/d41586-020-00444-3 · Cited by 133
The GlyCosmos Portal: a unified and comprehensive web resource for the glycosciences
Yamada, I., Shiota, M., Shinmachi, D., Ono, T., Tsuchiya, S., Hosoda, M., Fujita, A., Aoki, N. P., Watanabe, Y., Fujita, N., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-0879-8 · Cited by 132
Samama, M. M., Lensing, A. W. A., Buller, H. R., Barré, J., Vochelle, N., Beau, B., & Planès, A. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614411 · Cited by 132
Voglibose (Basen®, AO-128), One of the Most Important α-Glucosidase Inhibitors
Chen, X., Zheng, Y., & Shen, Y. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706789803035 · Cited by 129
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro
Morokutti-Kurz, M., Fröba, M., Graf, P., Große, M., Grassauer, A., Auth, J., Schubert, U., & Prieschl‐Grassauer, E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0237480 · Cited by 129
Hendel, R. C., Bateman, T. M., Cerqueira, M. D., Iskandrian, A. E., Leppo, J. A., Blackburn, B., & Mahmarian, J. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.097 · Cited by 128
Genomic diversity of mumps virus and global distribution of the 12 genotypes
Jin, L., Örvell, C., Myers, R. E., Rota, P. A., Nakayama, T., Forčić, D., Hiebert, J., & Brown, K. E. (2014) · Reviews in Medical Virology · doi:10.1002/rmv.1819 · Cited by 128
Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5′-polyphosphates
Pendergast, W., Yerxa, B. R., Douglass, J. G., Shaver, S. R., Dougherty, R. W., Redick, C. C., Sims, I. F., & Rideout, J. L. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00612-0 · Cited by 127
Miglustat: A Review of Its Use in Niemann-Pick Disease Type C
Lyseng-Williamson, K. A. (2013) · Drugs · doi:10.1007/s40265-013-0164-6 · Cited by 125
Gao, Z., Li, Z., Baker, S. P., Lasley, R. D., Meyer, S. M., Elzein, E. O., Palle, V. P., Zablocki, J. A., Blackburn, B. K., & Belardinelli, L. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29370-8 · Cited by 124
SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: Balancing benefits and risks
Taylor, S. I., Blau, J. E., Rother, K. I., & Beitelshees, A. L. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30154-8 · Cited by 124
van de Velde, F., Antipova, A. S., Rollema, H. S., Burova, T. V., Гринберг, Н. В., Pereira, L., Gilsenan, P. M., Tromp, R. H., Rudolph, B., & Grinberg, V. Y. (2005) · Carbohydrate Research · doi:10.1016/j.carres.2005.02.015 · Cited by 123
Planès, A., Samama, M. M., Lensing, A. W. A., et al. (1999) · PubMed · Cited by 122
In Vitro Activities of OPT-80 and Comparator Drugs against Intestinal Bacteria
Finegold, S. M., Molitoris, D. R., Väisänen, M., Song, Y., Liu, C., & Bolaňos, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4898-4902.2004 · Cited by 122
Carbohydrates as Scaffolds in Drug Discovery
Meutermans, W. D. F., Le, G. T., & Becker, B. (2006) · ChemMedChem · doi:10.1002/cmdc.200600150 · Cited by 122
New approaches from nanomedicine for treating leishmaniasis
Gutiérrez, V., Seabra, A. B., Reguera, R. M., Khandare, J. J., & Calderón, M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00674k · Cited by 121
The structure of nojirimycin, a piperidinose sugar antibiotic.
Inouye, S., Tsuruoka, T., & Nida, T. (1966) · PubMed · Cited by 120
Recent Developments in Synthetic Carbohydrate‐Based Diagnostics, Vaccines, and Therapeutics
Fernández‐Tejada, A., Cañada, F. J., & Jiménez‐Barbero, J. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201500831 · Cited by 120
Stress Myocardial Perfusion Imaging for Assessing Prognosis: An Update
Bourque, J. M., & Beller, G. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.10.003 · Cited by 120
Hepatitis elimination by 2030: Progress and challenges
Waheed, Y., Siddiq, M., Jamil, Z., & Najmi, M. H. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i44.4959 · Cited by 120
Susceptibilities of Legionella spp. to Newer Antimicrobials In Vitro
Schülin, T., Wennersten, C. B., Ferraro, M. J., Moellering, R. C., & Eliopoulos, G. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1520 · Cited by 119
Localization of ocular P2Y2 receptor gene expression by in situ hybridization
Cowlen, M. S., Zhang, V. Z., Warnock, L., Moyer, C. F., Peterson, W. M., & Yerxa, B. R. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00068-x · Cited by 119
Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome
Gallone, G., Baldetti, L., Pagnesi, M., Latib, A., Colombo, A., Libby, P., & Giannini, F. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.052 · Cited by 117
Yana, T., Negoro, S., Takada, M., Yokota, S., Takada, Y., Sugiura, T., Yamamoto, H., Sawa, T., Kawahara, M., Katakami, N., et al. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-9012-9 · Cited by 112
Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial
Ludwig, M., Enzenhofer, E., Schneider, S., Rauch, M., Bodenteich, A., Neumann, K., Prieschl‐Grassauer, E., Grassauer, A., Lion, T., & Mueller, C. A. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-124 · Cited by 111
Nishimura, R., Tanaka, Y., Koiwai, K., Inoue, K., Hach, T., Salsali, A., Lund, S. S., & Broedl, U. C. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0169-9 · Cited by 109
Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3)
Lin, W., Das, K., Degen, D., Mazumder, A., Duchi, D., Wang, D., Ebright, Y. W., Ebright, R. H., Sineva, E. V., Gigliotti, M., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.02.026 · Cited by 109
Yamashita, M. (2010) · Antiviral chemistry & chemotherapy · doi:10.3851/imp1688 · Cited by 108
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention
Généreux, P., Stone, G. W., Harrington, R. A., Gibson, C. M., Steg, P. G., Brener, S. J., Angiolillo, D. J., Price, M. J., Prats, J., LaSalle, L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.022 · Cited by 107
Combating evolution with intelligent design: the neoglycoside ACHN-490
Armstrong, E. S., & Miller, G. H. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.004 · Cited by 107
Ferreira, J. A., Magalhães, A., Gomes, J., Peixoto, A., Gaiteiro, C., Fernandes, E., Santos, L. L., & Reis, C. A. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.044 · Cited by 107
Hollander, P. A., Liu, J., Hill, J., Johnson, J. R., Jiang, Z. W., Golm, G. T., Huyck, S. B., Terra, S. G., Mancuso, J. P., Engel, S. S., et al. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0354-4 · Cited by 107
Advances in the preparation and synthesis of heparin and related products
Baytaş, S. N., & Linhardt, R. J. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.011 · Cited by 107
Hanada, M., Mizuno, S., Fukushima, A., Saito, Y. M., Noguchi, T., & Yamaoka, T. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00519.x · Cited by 106
Peters, A. L., Henry, R. R., Thakkar, P., Tong, C., & Alba, M. (2016) · Diabetes Care · doi:10.2337/dc15-1995 · Cited by 106
Ramesh, D., Vijayakumar, B. G., & Kannan, T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112801 · Cited by 106
Nie, J., Liu, L., Li, X., & Han, W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.010 · Cited by 105
Diquafosol Ophthalmic Solution 3 %: A Review of Its Use in Dry Eye
Keating, G. M. (2015) · Drugs · doi:10.1007/s40265-015-0409-7 · Cited by 104
Gandhi, V. V., Plunkett, W. K., Rodriguez, C. O., Nowak, B. J., Du, M., Ayres, M., Kisor, D. F., Mitchell, B. S., Kurtzberg, J., & Keating, M. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3607 · Cited by 103
Canagliflozin and cardiovascular and renal events in type 2 diabetes
Guthrie, R. M. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1423852 · Cited by 102
Imaging Bacterial Cell Wall Biosynthesis
Radkov, A. D., Hsu, Y.-P., Booher, G., & VanNieuwenhze, M. S. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012921 · Cited by 102
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections
Eljaaly, K., Alharbi, A., Alshehri, S., Ortwine, J. K., & Pogue, J. M. (2019) · Drugs · doi:10.1007/s40265-019-1054-3 · Cited by 99
Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir
Peng, Q., Peng, R., Yuan, B., Wang, M., Zhao, J., Fu, L., Qi, J., & Shi, Y. (2021) · The Innovation · doi:10.1016/j.xinn.2021.100080 · Cited by 99
Tiwari, V. K., Mishra, R. C., Sharma, A., & Tripathi, R. P. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712803832654 · Cited by 98
Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic
Saravolatz, L. D., Billeter, M., Zervos, M., Chen, A. Y., Dalovisio, J. R., & Kurukularatne, C. (2008) · Clinical Infectious Diseases · doi:10.1086/526772 · Cited by 96
Telavancin: Mechanisms of Action, In Vitro Activity, and Mechanisms of Resistance
Karlowsky, J. A., Nichol, K. A., & Zhanel, G. G. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ534 · Cited by 96
Azvudine (FNC): a promising clinical candidate for COVID-19 treatment
Yu, B., & Chang, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00351-z · Cited by 96
Self-citationRodbard, H. W., Peters, A. L., Slee, A., Cao, A., Traina, S. B., & Alba, M. (2017) · Diabetes Care · doi:10.2337/dc16-1353 · Cited by 94
Azad, A. K., Rajaram, M. V. S., Metz, W., Cope, F. O., Blue, M., Vera, D. R., & Schlesinger, L. S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402005 · Cited by 94
Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections
Alame, M. M., Massaad, E., & Zaraket, H. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00450 · Cited by 94
Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance
Andrews, J. R., Baker, S. G., Marks, F., Alsan, M. M., Garrett, D. O., Gellin, B. G., Saha, S. K., Qamar, F. N., Yousafzai, M. T., Bogoch, I. I., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30350-5 · Cited by 93
Luseogliflozin: First Global Approval
Markham, A., & Elkinson, S. (2014) · Drugs · doi:10.1007/s40265-014-0230-8 · Cited by 92
Xie, C., Li, X., Wu, J., Liang, Z., Deng, F., Xie, W., Zhu, M., Zhu, J., Zhu, W., Geng, S., et al. (2015) · Inflammation · doi:10.1007/s10753-015-0140-2 · Cited by 91
Chemical glycobiology: why now?
Seeberger, P. H. (2009) · Nature Chemical Biology · doi:10.1038/nchembio0609-368 · Cited by 91
The Virtual Physiological Human: Ten Years After
Viceconti, M., & Hunter, P. J. (2016) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110915-114742 · Cited by 91
Disease-associated glycans on cell surface proteins
Takahashi, M., Kizuka, Y., Ohtsubo, K., Gu, J., & Taniguchi, N. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.04.008 · Cited by 91
Connolly, L. E., Riddle, V., Cebrik, D., Armstrong, E. S., & Miller, L. G. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01989-17 · Cited by 90
Carbohydrate‐based vaccines for oncotherapy
Wei, M., Wang, Y., & Ye, X. (2018) · Medicinal Research Reviews · doi:10.1002/med.21493 · Cited by 88
Venous and arterial thrombosis: Different sides of the same coin?
Franchini, M., & Mannucci, P. M. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.10.019 · Cited by 86
Migalastat: First Global Approval
Markham, A. (2016) · Drugs · doi:10.1007/s40265-016-0607-y · Cited by 86
Canagliflozin: First Global Approval
Elkinson, S., & Scott, L. J. (2013) · Drugs · doi:10.1007/s40265-013-0064-9 · Cited by 82
Mechanisms for T-cell selective cytotoxicity of arabinosylguanine
Rodriguez, C. O., Stellrecht, C. M., & Gandhi, V. V. (2003) · Blood · doi:10.1182/blood-2003-01-0317 · Cited by 82
Ison, G., Beaver, J. A., McGuinn, W. D., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0638 · Cited by 81
Tanizawa, Y., Kaku, K., Araki, E., Tobe, K., Terauchi, Y., Utsunomiya, K., Iwamoto, Y., Watada, H., Ohtsuka, W., Watanabe, D., et al. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.887680 · Cited by 80
Morisada, S., Yanagi, Y., Noguchi, T., Kashiwazaki, Y., & Fukui, M. (1989) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1989.tb02247.x · Cited by 80
Shortridge, V. D., Zhong, P., Cao, Z., Beyer, J. M., Almer, L. S., Ramer, N. C., Doktor, S. Z., & Flamm, R. K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.783-786.2002 · Cited by 78
Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation
Kansara, M., Leong, H. S., Lin, D., Popkiss, S., Pang, P., Garsed, D. W., Walkley, C. R., Cullinane, C. M., Ellul, J., Haynes, N. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70559 · Cited by 78
Ertugliflozin: First Global Approval
Markham, A. (2018) · Drugs · doi:10.1007/s40265-018-0878-6 · Cited by 78
Characterization of platelet binding of heparins and other glycosaminoglycans
Sobel, M., & Adelman, B. (1988) · Thrombosis Research · doi:10.1016/0049-3848(88)90341-6 · Cited by 77
Glycoconjugates for glucose transporter-mediated cancer-specific targeting and treatment
Fu, J., Yang, J., Seeberger, P. H., & Yin, J. (2020) · Carbohydrate Research · doi:10.1016/j.carres.2020.108195 · Cited by 76
Sun, L. J., Peng, Y., Yu, W., Zhang, Y., Liang, L., Song, C., Hou, J., Qiao, Y., Wang, Q., Chen, J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00940 · Cited by 74
Self-citationRecent progress and advanced technology in carbohydrate-based drug development
Pan, L., Cai, C., Liu, C., Liu, D., Li, G., Linhardt, R. J., & Yu, G. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.12.023 · Cited by 72
Rodriguez, C. O., Mitchell, B. S., Ayres, M., Eriksson, S., & Gandhi, V. V. (2002) · PubMed · Cited by 71
Fogler, W. E., Wade, R. E., BRUNDISH, D. E., & Fidler, I. J. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.2.1372 · Cited by 71
Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery
Zhao, K., Liu, A., & Xia, Y. (2020) · The Innovation · doi:10.1016/j.xinn.2020.100034 · Cited by 71
DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension
Licht, J. D. (2015) · Cell · doi:10.1016/j.cell.2015.08.005 · Cited by 69
Management of chronic constipation in patients with diabetes mellitus
Prasad, V. G. M., & Abraham, P. (2016) · Indian Journal of Gastroenterology · doi:10.1007/s12664-016-0724-2 · Cited by 68
Vaccination against Salmonella Infection: the Mucosal Way
Gayet, R., Bioley, G., Rochereau, N., Paul, S., & Corthésy, B. (2017) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00007-17 · Cited by 67
Yamamoto, K., Uchida, S., Kitano, K., Fukuhara, N., Okumura-Kitajima, L., Gunji, E., Kozakai, A., Tomoike, H., Kojima, N., Asami, J., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01340.x · Cited by 66
Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia
Scott, L. J. (2016) · Drugs · doi:10.1007/s40265-016-0585-0 · Cited by 66
Sotagliflozin: First Global Approval
Markham, A., & Keam, S. J. (2019) · Drugs · doi:10.1007/s40265-019-01146-5 · Cited by 64
Antithrombotic P2Y12 receptor antagonists: recent developments in drug discovery
Baqi, Y., & Müller, C. E. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.09.021 · Cited by 63
Seeberger, P. H., & Rademacher, C. (2014) · Topics in medicinal chemistry · doi:10.1007/978-3-319-08675-0 · Cited by 62
Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections
Hammerschlag, M. R., & Sharma, R. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.3.387 · Cited by 62
McCormack, P. L., & Goa, K. L. (2003) · Drugs · doi:10.2165/00003495-200363220-00006 · Cited by 62
Carbohydrate drugs: current status and development prospect
Zhang, Y., & Wang, F. (2015) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2015.01028 · Cited by 61
Sugammadex: the first selective binding reversal agent for neuromuscular block
Kovac, A. L. (2009) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2009.05.002 · Cited by 61
Accelerating global innovation to address antibacterial resistance: introducing CARB-X
Outterson, K., Rex, J. H., Jinks, T., Jackson, P., Hallinan, J., Karp, S., Hung, D. T., Franceschi, F. J., Merkeley, T. G., Houchens, C. R., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.155 · Cited by 61
Sone, S., Mutsuura, S., Ogawara, M., & Tsubura, E. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.4.2105 · Cited by 59
Jomaa, A., Stewart, G., Martín‐Benito, J., Zielke, R. A., Campbell, T., Maddock, J. R., Brown, E. D., & Ortega, J. (2011) · RNA · doi:10.1261/rna.2509811 · Cited by 59
Entecavir: a potent new antiviral drug for hepatitis B
Honkoop, P., & de Man, R. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.4.683 · Cited by 59
Renal glucose transporters: novel targets for hyperglycemia management
Mather, A., & Pollock, C. A. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.38 · Cited by 58
Recent advances and future perspectives on carbohydrate-based cancer vaccines and therapeutics
Sorieul, C., Papi, F., Carboni, F., Pecetta, S., Phogat, S. K., & Adamo, R. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108158 · Cited by 57
Dharmalingam, M., Aravind, S. R., Thacker, H. P., Shamanna, P., Mohan, B., Chawla, M. S., Asirvatham, A. J., Goyal, R., Shembalkar, J., Balamurugan, R., et al. (2020) · Drugs · doi:10.1007/s40265-020-01285-0 · Cited by 56
Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review
Haider, K., Pathak, A., Rohilla, A., Haider, M. R., Ahmad, K., & Yar, M. S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111773 · Cited by 55
Pui, C., Jeha, S., & Kirkpatrick, P. N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1724 · Cited by 55
In Vitro Activities of ABT-773 and Other Antimicrobials against Human Mycoplasmas
Waites, K. B., Crabb, D. M., & Duffy, L. B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.39-42.2003 · Cited by 54
Miller, L. E., Tennilä, J., & Ouwehand, A. C. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s58952 · Cited by 53
Corey, G. R., Stryjewski, M. E., Weyenberg, W., Yasothan, U., & Kirkpatrick, P. N. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd3051 · Cited by 53
Waud, W. R., Schmid, S. M., Montgomery, J. A. J., & Secrist, J. A. I. (2000) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770008033020 · Cited by 51
Rare lung disease and orphan drug development
Spagnolo, P., du Bois, R. M., & Cottin, V. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70085-7 · Cited by 50
Kaku, K., Isaka, H., Sakatani, T., & Toyoshima, J. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13807 · Cited by 50
Glycomics, Glycoproteomics, and Glycogenomics: An Inter-Taxa Evolutionary Perspective
West, C. M., Malzl, D., Hykollari, A., & Wilson, I. B. H. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r120.002263 · Cited by 50
Pneumococcal Vaccines: Past Findings, Present Work, and Future Strategies
Oliveira, G. S., Oliveira, M. L. S., Miyaji, E. N., & Rodrigues, T. C. (2021) · Vaccines · doi:10.3390/vaccines9111338 · Cited by 50
Tracing investment in drug development for Alzheimer disease
Kodamullil, A. T., Zekri, F., Sood, M., Hengerer, B., Canard, L., McHale, D., & Hofmann‐Apitius, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.169 · Cited by 49
Gandhi, V. V., Keating, M. J., Bate, G., & Kirkpatrick, P. N. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1933 · Cited by 49
Current status of data on cangrelor
Qamar, A., & Bhatt, D. L. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.004 · Cited by 48
Mechanism and evidence of nonsense suppression therapy for genetic eye disorders
Richardson, R., Smart, M. J. K., Tracey‐White, D., Webster, A. R., & Moosajee, M. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.01.001 · Cited by 48
From Vancomycin to Oritavancin: The Discovery and Development of a Novel Lipoglycopeptide Antibiotic
Allen, N. E. (2010) · Anti-Infective Agents · doi:10.2174/187152110790886745 · Cited by 47
Immunology of carbohydrate-based vaccines
Khatun, F., Tóth, I., & Stephenson, R. J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.006 · Cited by 45
Cheng, Y., Zhang, J., Shang, J., & Zhang, L. (2009) · Pharmacology · doi:10.1159/000235873 · Cited by 43
Diagnosis and Treatment of Clostridioides ( Clostridium ) difficile Infection in Adults in 2020
Rao, K. K., & Malani, P. (2020) · JAMA · doi:10.1001/jama.2019.3849 · Cited by 43
Miglitol may have a blood glucose lowering effect unrelated to inhibition of alpha-glucosidase
Joubert, P. H., Foukaridis, G. N., & Bopape, M. (1987) · European Journal of Clinical Pharmacology · doi:10.1007/bf00541303 · Cited by 42
Sugiura, T., Ariyoshi, Y., Negoro, S., et al. (2005) · Investigational New Drugs · doi:10.1007/s10637-005-1441-3 · Cited by 42
SGLT2 inhibitors in people with and without T2DM
Khunti, K. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00453-2 · Cited by 42
Saba, H. I., Rosenfeld, C. S., Issa, J. J., DiPersio, J. F., Raza, A., Klimek, V. M., Slack, J. L., de Castro, C., Mettinger, K. L., & Kantarjian, H. M. (2004) · Blood · doi:10.1182/blood.v104.11.67.67 · Cited by 41
History and future of shotgun glycomics
Smith, D. F., Cummings, R. D., & Song, X. (2019) · Biochemical Society Transactions · doi:10.1042/bst20170487 · Cited by 40
Yan, H., Sun, J., Wang, K., Wang, H., Wu, S., Bao, L., He, W., Wang, D., Zhu, A., Zhang, T., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.024 · Cited by 39
The role of P2Y12 receptor in ischemic stroke of atherosclerotic origin
Gao, Y., Yu, C. J., Pi, S., Mao, L., & Hu, B. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2937-2 · Cited by 38
Baigent, S. J., Bethell, R. C., & McCauley, J. W. (1999) · Virology · doi:10.1006/viro.1999.9931 · Cited by 36
COVID-19: Perspectives on the Potential Novel Global Threat
Gentile, I., & Abenavoli, L. (2020) · Reviews on Recent Clinical Trials · doi:10.2174/18761038mta0jodke3 · Cited by 36
SGLT2 inhibitors, an Accomplished Development in Field of Medicinal Chemistry: an Extensive Review
Manoj, A., Das, S., Ramachandran, A. K., Alex, A. T., & Joseph, A. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0154 · Cited by 36
Regulation of the absorption of dietary carbohydrate in man by two new glycosidase inhibitors.
Taylor, R. H., Barker, H. M., Bowey, E. A., & Canfield, J. E. (1986) · Gut · doi:10.1136/gut.27.12.1471 · Cited by 35
Synthetic heparin and heparan sulfate: probes in defining biological functions
Tsai, C., Zulueta, M. M. L., & Hung, S. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.09.012 · Cited by 35
Fidaxomicin: a new option for the treatment of Clostridium difficile infection
Johnson, A. P., & Wilcox, M. H. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks302 · Cited by 34
Deeks, E. D. (2011) · Drugs · doi:10.2165/11206850-000000000-00000 · Cited by 34
Keam, S. J. (2007) · Drugs · doi:10.2165/00003495-200767130-00011 · Cited by 34
Friedel, H. A., & Balfour, J. A. B. (1994) · Drugs · doi:10.2165/00003495-199448040-00010 · Cited by 33
Frean, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg364 · Cited by 33
Sugar recognition and protein–protein interaction of mammalian lectins conferring diverse functions
Nagae, M., & Yamaguchi, Y. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.08.005 · Cited by 31
Carbohydrate-based templates for synthetic vaccines and drug delivery
McGeary, R. P., Jablonkai, I., & Tóth, I. (2001) · Tetrahedron · doi:10.1016/s0040-4020(01)00852-3 · Cited by 31
Three New Drugs for Acute Lymphoblastic Leukemia: Nelarabine, Clofarabine, and Forodesine
Larson, R. A. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.11.002 · Cited by 31
Palle, V. P., Elzein, E. O., Gothe, S. A., Li, Z., Gao, Z., Meyer, S. M., Blackburn, B. K., & Zablocki, J. A. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00609-1 · Cited by 30
C-Glucosides with heteroaryl thiophene as novel sodium-dependent glucose cotransporter 2 inhibitors
Koga, Y., Sakamaki, S., Hongu, M., Kawanishi, E., Sakamoto, T., Yamamoto, Y., Kimata, H., Nakayama, K., Kuriyama, C., Matsushita, Y., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.05.048 · Cited by 29
Synthetic Carbohydrate Chemistry and Translational Medicine
Shivatare, S. S., & Wong, C. (2020) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.0c01834 · Cited by 29
Ma, H., Zeng, M.-D., Chen, Y., Cw, C., Qc, F., Cai, X., Wu, S.-M., Yg, C., Ying, S., Li, J., et al. (2009) · PubMed · Cited by 27
Fogarty, C. M., de Wet, R., Mandell, L. A., Chang, J. R., Rangaraju, M., & Nusrat, R. (2005) · CHEST Journal · doi:10.1378/chest.128.4.1980 · Cited by 26
Kojima, T., Doğru, M., Ibrahim, O. M., Nagata, T., Higa, K., Shimizu, T., Shirasawa, T., Satake, Y., Shimazaki-Den, S., Shimazaki, J., et al. (2014) · PubMed Central · Cited by 26
Mueller‐Lissner, S., & Wald, A. M. (2010) · Europe PMC (PubMed Central) · Cited by 25
Medical Treatment for Dry Eye in Japan
Watanabe, H. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24130 · Cited by 25
Clevudine: a promising therapy for the treatment of chronic hepatitis B
Asselah, T., Lada, O., Moucari, R., & Marcellin, P. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802535760 · Cited by 22
Hatakeyama, Y., Kobayashi, K., Nagano, T., Tamura, D., Yamamoto, M., TACHIHARA, M. Y., Kotani, Y., & Nishimura, Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.019 · Cited by 21
The role of dinucleoside polyphosphates on the ocular surface and other eye structures
Carracedo, G., Crooke, A., Guzmán‐Aránguez, A., de Lara, M. J. P., Martín‐Gil, A., & Pintor, J. J. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.07.001 · Cited by 21
Biomarkers for the early detection of PDAC
Ray, K. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.111 · Cited by 20
Comparative activity of telithromycin against typical community-acquired respiratory pathogens
Buxbaum, A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg359 · Cited by 19
Anti-Influenza Drug Discovery: Are We Ready for the Next Pandemic?
Islam, T. F., & von Itzstein, M. (2007) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/s0065-2318(07)61006-3 · Cited by 16
Interactions of aminoglycoside antibiotics with rRNA
Trylska, J., & Kulik, M. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160087 · Cited by 16
Ticagrelor: A Review in Long Term Secondary Prevention of Cardiovascular Events
Al-Salama, Z. T., Keating, G. M., & Keam, S. J. (2017) · Drugs · doi:10.1007/s40265-017-0844-8 · Cited by 14
A pharmacological chaperone on the horizon
Gaggl, M., & Sunder–Plassmann, G. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.138 · Cited by 13
Luna, V. A., Xu, Z.-Q., Eiznhamer, D. A., Cannons, A. C., & Cattani, J. A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn227 · Cited by 9
Boons, G., & Wu, P. (2016) · Glycobiology · doi:10.1093/glycob/cww072 · Cited by 8
Xiao, X., & Shifu (2019) · 中国药理学与毒理学杂志 · Cited by 1
Metadata
- Authors
- Cao, X., Du, X., Jiao, H., An, Q., Chen, R., Fang, P., Wang, J., & Yu, B.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2022-10
- Volume
- 12
- Issue
- 10
- Pages
- 3783-3821
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W4281390765
- Cited by
- 267
- References
- 397
- FWCI
- 19.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.